Figure 2.

Follow up chest imaging and bronchoscopic findings during the cancer treatment. (A) Chest CT taken after 2 months of erlotinib treatment and (B) after 8 months showing interval increased bronchial wall thickening and nodular opacities in RUL compared to those taken 6 months ago; (C) bronchoscopic findings of the patient after 8 months’ treatment. Whitish mucosal plaques with mucus secretion were noted at RUL bronchus. Mucosal cancer infiltration was improved compared to previous exam. RUL, right upper lobe.